Rating History for ImmunoCellular Therapeutics (IMUC) by Roth/MKM

More Stocks Rated by Roth/MKM | Latest Ratings for IMUC
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/24/2015 N/A Maintain Buy
(N/A)		 3.00
(N/A)		  
 		   Details